XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.2
STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Sep. 30, 2023   1,581,188    
Balance, amount at Sep. 30, 2023 $ 13,214,890 $ 15,811 $ 500,290,475 $ (487,091,396)
401(k) contributions paid in common stock, shares   591    
401(k) contributions paid in common stock, amount 48,907 $ 6 48,901 0
Stock issued to nonemployees for service, shares   2,952    
Stock issued to nonemployees for service, amount 202,307 $ 30 202,277 0
Proceeds from the sale of common stock, shares   83,000    
Proceeds from the sale of common stock, amount 4,980,000 $ 830 4,979,170 0
Equity based compensation - employees 1,383,909 0 1,383,909 0
Share issuance costs (470,229) 0 (470,229) 0
Net loss (6,709,524) $ 0 0 (6,709,524)
Balance, shares at Dec. 31, 2023   1,667,731    
Balance, amount at Dec. 31, 2023 12,650,260 $ 16,677 506,434,503 (493,800,920)
Balance, shares at Sep. 30, 2023   1,581,188    
Balance, amount at Sep. 30, 2023 13,214,890 $ 15,811 500,290,475 (487,091,396)
Net loss (20,810,973)      
Balance, shares at Jun. 30, 2024   1,809,040    
Balance, amount at Jun. 30, 2024 8,473,057 $ 18,089 516,357,337 (507,902,369)
Balance, shares at Dec. 31, 2023   1,667,731    
Balance, amount at Dec. 31, 2023 12,650,260 $ 16,677 506,434,503 (493,800,920)
401(k) contributions paid in common stock, shares   912    
401(k) contributions paid in common stock, amount 53,485 $ 9 53,476 0
Stock issued to nonemployees for service, shares   5,425    
Stock issued to nonemployees for service, amount 380,870 $ 54 380,816 0
Proceeds from the sale of common stock, shares   129,167    
Proceeds from the sale of common stock, amount 7,750,000 $ 1,292 7,748,708 0
Equity based compensation - employees 1,432,540 0 1,432,540 0
Share issuance costs (717,621) 0 (717,621) 0
Net loss (7,244,891) $ 0 0 (7,244,891)
Balance, shares at Mar. 31, 2024   1,803,235    
Balance, amount at Mar. 31, 2024 14,304,643 $ 18,032 515,332,422 (501,045,811)
401(k) contributions paid in common stock, shares   1,524    
401(k) contributions paid in common stock, amount 60,577 $ 15 60,562 0
Stock issued to nonemployees for service, shares   2,348    
Stock issued to nonemployees for service, amount 155,655 $ 23 155,632 0
Equity based compensation - employees 728,120 0 728,120 0
Net loss (6,856,558) $ 0 0 (6,856,558)
Purchase of stock by officers and directors, shares   1,933    
Purchase of stock by officers and directors, amount 80,620 $ 19 80,601 0
Balance, shares at Jun. 30, 2024   1,809,040    
Balance, amount at Jun. 30, 2024 8,473,057 $ 18,089 516,357,337 (507,902,369)
Balance, shares at Sep. 30, 2024   2,126,682    
Balance, amount at Sep. 30, 2024 12,867,083 $ 21,266 526,857,678 (514,011,861)
401(k) contributions paid in common stock, shares   4,761    
401(k) contributions paid in common stock, amount 57,134 $ 48 57,086 0
Stock issued to nonemployees for service, shares   5,154    
Stock issued to nonemployees for service, amount 396,087 $ 52 396,035 0
Proceeds from the sale of common stock, shares   251,750    
Proceeds from the sale of common stock, amount 5,000,300 $ 2,518 4,997,782 0
Equity based compensation - employees 711,381 (1) 711,382 0
Share issuance costs (650,291) 0 (650,291) 0
Net loss (7,073,062) $ 0 0 (7,073,062)
Pre-funded warrant exercises, shares   48,333    
Pre-funded warrant exercises, amount 0 $ 483 (483) 0
Equity based compensation - employees, shares   (100)    
Balance, shares at Dec. 31, 2024   2,436,580    
Balance, amount at Dec. 31, 2024 11,308,632 $ 24,366 532,369,189 (521,084,923)
Balance, shares at Sep. 30, 2024   2,126,682    
Balance, amount at Sep. 30, 2024 12,867,083 $ 21,266 526,857,678 (514,011,861)
Net loss (19,310,155)      
Balance, shares at Jun. 30, 2025   5,321,341    
Balance, amount at Jun. 30, 2025 7,024,940 $ 53,214 540,293,742 (533,322,016)
Balance, shares at Dec. 31, 2024   2,436,580    
Balance, amount at Dec. 31, 2024 11,308,632 $ 24,366 532,369,189 (521,084,923)
401(k) contributions paid in common stock, shares   7,524    
401(k) contributions paid in common stock, amount 54,054 $ 75 53,979 0
Stock issued to nonemployees for service, shares   1,667    
Stock issued to nonemployees for service, amount 60,202 $ 17 60,185 0
Proceeds from the sale of common stock, shares   133,750    
Proceeds from the sale of common stock, amount 2,560,000 $ 1,338 2,558,662 0
Equity based compensation - employees 685,668 0 685,668 0
Share issuance costs (449,197) 0 (449,197) 0
Net loss (6,572,389) $ 0 0 (6,572,389)
Pre-funded warrant exercises, shares   199,250    
Pre-funded warrant exercises, amount 0 $ 1,993 (1,993) 0
Shares issued for settlement of clinical development costs, shares   33,333    
Shares issued for settlement of clinical development costs, amount 350,885 $ 333 350,552 0
Balance, shares at Mar. 31, 2025   2,812,104    
Balance, amount at Mar. 31, 2025 7,997,855 $ 28,122 535,627,045 (527,657,312)
401(k) contributions paid in common stock, shares   22,986    
401(k) contributions paid in common stock, amount 53,323 $ 230 53,093 0
Stock issued to nonemployees for service, amount 127,158 $ 0 127,158 0
Proceeds from the sale of common stock, shares   2,000,000    
Proceeds from the sale of common stock, amount 5,000,000 $ 20,000 4,980,000 0
Equity based compensation - employees 73,442 0 73,442 0
Share issuance costs (562,134) 0 (562,134) 0
Net loss (5,664,704) $ 0 0 (5,664,704)
Pre-funded warrant exercises, shares   486,251    
Pre-funded warrant exercises, amount 0 $ 4,862 (4,862) 0
Balance, shares at Jun. 30, 2025   5,321,341    
Balance, amount at Jun. 30, 2025 $ 7,024,940 $ 53,214 $ 540,293,742 $ (533,322,016)